ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

NITE Nightstar Therapeutics Plc ADS

25.41
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
Nightstar Therapeutics Plc ADS NASDAQ:NITE NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 25.41 18.50 25.41 0 01:00:00

Knight Launches Real-Time Global Transaction Cost Analysis Product Suite

19/11/2008 1:00pm

PR Newswire (US)


Nightstar Therapeutics Plc ADS (NASDAQ:NITE)
Historical Stock Chart


From Jul 2019 to Jul 2024

Click Here for more Nightstar Therapeutics Plc ADS Charts.
Suite offers risk-mitigating tools to better help clients achieve their trading objectives JERSEY CITY, N.J., Nov. 19 /PRNewswire-FirstCall/ -- Knight Capital Group, Inc. (NASDAQ:NITE) today announced the launch of its real-time global transaction cost analysis product suite designed for clients using Knight's electronic and voice trade execution offerings. This new product suite provides clients with market insights and decision-support capabilities with both pre- and post-trade analysis to achieve their trading objectives. When trading with Knight electronically, clients can utilize the new trade cost analysis product suite on the Knight Client Center, Knight's web-based portal, and through Knight Direct EMSTM, Knight's broker-neutral multi-asset class trading platform. Through both platforms clients are able to monitor all orders and trades with real-time profit and loss measurements. When utilizing our program trading services, via Knight's voice offering, clients can work directly with their program sales professionals to track their trades throughout the day and then use the suite's real-time Portfolio Monitoring tool to track their progress. "Clients in today's highly volatile market are demanding improved transaction cost analysis tools," said Bill Cronin, Managing Director at Knight. "Our new product suite brings this to our clients on a real-time, global basis." Knight's real-time global transaction cost analysis product suite provides clients with the information they require when managing the execution of a portfolio of securities spanning a wide array of sectors, market capitalization and liquidity. Clients can upload their portfolios anonymously and generate pre-trade reports that provide comprehensive analytics including transaction cost forecasting, risk analysis using statistical risk models, historical time-series performance analysis and real-time portfolio trading monitoring. Traders and managers can easily evaluate individual, algorithmic and strategy performance on orders executed, and are also able to view market impacting factors such as percentage of intra-day volume and percentage of average daily volume (ADV). This analysis can be run against a single basket or an entire quarter's trade activity and the performance can be displayed against numerous benchmarks in both a graphical and tabular format. Post-trade analytical functionality allows clients to run historical reports for the day, month or quarter, providing clients with valuable feedback to help in managing risk exposure and planning the execution of future trades. In addition, clients can view their profit and loss results across various aggregation points including sector, market capitalization and liquidity. About Knight Knight Capital Group, Inc. (NASDAQ:NITE) is a leading capital markets firm that provides electronic and voice access to the global capital markets across multiple asset classes for buy-side, sell-side and corporate clients. In Global Markets, we provide market access and trade execution services in nearly every U.S. equity security and a large number of international securities, fixed income, foreign exchange, futures and options. In Asset Management, Knight owns a 51 percent stake in Deephaven Holdings with Deephaven Partners controlling the remaining 49 percent as of February 1, 2008. Deephaven (http://www.deephavenfunds.com/) is a global, multi-strategy alternative investment manager serving institutions and private clients. More information about Knight can be found at http://www.knight.com/. Certain statements contained herein, may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are not historical facts and are based on current expectations, estimates and projections about the Company's industry, management's beliefs and certain assumptions made by management, many of which, by their nature, are inherently uncertain and beyond our control. Accordingly, readers are cautioned that any such forward-looking statements are not guarantees of future performance and are subject to certain risks, uncertainties and assumptions that are difficult to predict including, without limitation, risks associated with the costs, integration, performance and operation of businesses recently acquired, or that may be acquired in the future, by the Company, and risks associated with the unprecedented current market conditions and the resulting volatility, credit tightening and counterparty risk, as well as the negative effect on performance and assets under management in our Asset Management business and the suspension of redemptions and withdrawals announced in the Form 8-K filed by the Company on October 30, 2008. Since such statements involve risks and uncertainties, the actual results and performance of the Company may turn out to be materially different from the results expressed or implied by such forward-looking statements. Given these uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements. Unless otherwise required by law, the Company also disclaims any obligation to update its view of any such risks or uncertainties or to announce publicly the result of any revisions to the forward-looking statements made herein. Readers should carefully review the risks and uncertainties disclosed in the Company's reports with the U.S. Securities and Exchange Commission (SEC), including, without limitation, those detailed under the headings "Certain Factors Affecting Results of Operations" and "Risk Factors" in the Company's Annual Report on Form 10-K for the year-ended December 31, 2007, and in other reports or documents the Company files with, or furnishes to, the SEC from time to time. This information should also be read in conjunction with the Company's Consolidated Financial Statements and the Notes thereto contained in the Company's Annual Report on Form 10-K for the year-ended December 31, 2007, and in other reports or documents the Company files with, or furnishes to, the SEC from time to time. DATASOURCE: Knight Capital Group, Inc. CONTACT: Margaret Wyrwas, Senior Managing Director, Communications, Marketing & Investors Relations, +1-201-557-6954, ; or Kara Fitzsimmons, Director, Media Relations, +1-201-356-1523, ; or Jonathan Mairs, Vice President, Corporate Communications, +1-201-356-1529, , or Mary Gilbert, Vice President, Marketing Communications, +1-201-386-2825, , or Ludwig Marek, Vice President, Marketing Communications, +1-201-356-1506, , all of Knight Capital Group, Inc. Web Site: http://www.deephavenfunds.com/ http://www.knight.com/

Copyright

1 Year Nightstar Therapeutics Plc ADS Chart

1 Year Nightstar Therapeutics Plc ADS Chart

1 Month Nightstar Therapeutics Plc ADS Chart

1 Month Nightstar Therapeutics Plc ADS Chart